IONLACE
Ionlace provides scalable proteomics tools that use AI to accelerate biomedical research. Its Radiant platform combines real-world AI with synthetic biology to design experiments and perform lab work more efficiently. It serves researchers and healthcare organizations through modular protein technologies and biological data services focused on proteomics and preventative health. The approach aims to deliver actionable biomarkers and broaden access to advanced biotech tools at scale.
IONLACE
Ionlace provides scalable proteomics tools that use AI to accelerate biomedical research. Its Radiant platform combines real-world AI with synthetic biology to design experiments and perform lab work more efficiently. It serves researchers and healthcare organizations through modular protein technologies and biological data services focused on proteomics and preventative health. The approach aims to deliver actionable biomarkers and broaden access to advanced biotech tools at scale.
TL;DR
Founded: 2023
Headquarters: Solna, Sweden
Team size: Approximately 13 employees
Core product: Radiant — AI + lab-in-the-loop platform for modular protein design and proteomics
Funding: No public funding rounds recorded
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Proteomics, modular protein design and engineering biology for medicine and preventative health.
Founded
2023
Industry
Biotechnology